Company intelligence / Profile preview

Jomed

Helsingborg, Sweden

Ownership: Private
Employees: ~700
Development stage: Other

Overview

Jomed was a prominent medical technology company specializing in minimally invasive products for interventional cardiology and vascular surgery. The company was widely recognized for its "Jostent" product line, which included innovative stent grafts and coronary stents used to treat cardiovascular diseases. In 2003, the company faced a catastrophic collapse due to a high-profile accounting scandal involving the falsification of financial records. Following its bankruptcy, Jomed's vascular business was acquired by Abbott Laboratories, and its intravascular ultrasound (IVUS) assets were sold to Volcano Therapeutics.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Jomed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jomed.

Explore the full profile